217 related articles for article (PubMed ID: 9061357)
1. Recognition of cytoplasmic yeast antigens of Cryptococcus neoformans var. neoformans and Cryptococcus neoformans var. gattii by immune human sera.
Hamilton AJ; Figueroa JI; Jeavons L; Seaton RA
FEMS Immunol Med Microbiol; 1997 Feb; 17(2):111-9. PubMed ID: 9061357
[TBL] [Abstract][Full Text] [Related]
2. Murine monoclonal antibodies recognizing a non-capsular antigen that distinguishes between Cryptococcus neoformans var. neoformans and C. neoformans var. gattii.
Hamilton AJ; Bartholomew MA; Figueroa J; Fenelon LE; Hay RJ
Trans R Soc Trop Med Hyg; 1991; 85(1):123-7. PubMed ID: 2068741
[TBL] [Abstract][Full Text] [Related]
3. A 34- to 38-kilodalton Cryptococcus neoformans glycoprotein produced as an exoantigen bearing a glycosylated species-specific epitope.
Hamilton AJ; Jeavons L; Hobby P; Hay RJ
Infect Immun; 1992 Jan; 60(1):143-9. PubMed ID: 1370270
[TBL] [Abstract][Full Text] [Related]
4. Biochemical comparison of the Cu,Zn superoxide dismutases of Cryptococcus neoformans var. neoformans and Cryptococcus neoformans var. gattii.
Hamilton AJ; Holdom MD
Infect Immun; 1997 Feb; 65(2):488-94. PubMed ID: 9009302
[TBL] [Abstract][Full Text] [Related]
5. Effects of the two varieties of Cryptococcus neoformans cells and culture filtrate antigens on neutrophil locomotion.
Dong ZM; Murphy JW
Infect Immun; 1995 Jul; 63(7):2632-44. PubMed ID: 7790079
[TBL] [Abstract][Full Text] [Related]
6. Experimental systemic infection with Cryptococcus neoformans var. grubii and Cryptococcus gattii in normal and immunodeficient mice.
Capilla J; Maffei CM; Clemons KV; Sobel RA; Stevens DA
Med Mycol; 2006 Nov; 44(7):601-10. PubMed ID: 17071553
[TBL] [Abstract][Full Text] [Related]
7. Cryptococcus neoformans varieties as agents of cryptococcosis in Brazil.
Rozenbaum R; Gonçalves AJ; Wanke B; Caiuby MJ; Clemente H; Lazera Mdos S; Monteiro PC; Londero AT
Mycopathologia; 1992 Sep; 119(3):133-6. PubMed ID: 1435954
[TBL] [Abstract][Full Text] [Related]
8. Analysis of antibody response to Cryptococcus neoformans in five patients with AIDS and cryptococcosis by immunoblotting.
Lamura L; Matthews RC; Barchiesi F; Donahoe M; Burnie JP; Scalise G
J Infect; 2000 Jan; 40(1):64-8. PubMed ID: 10762114
[TBL] [Abstract][Full Text] [Related]
9. Serotyping of Cryptococcus neoformans by using a monoclonal antibody specific for capsular polysaccharide.
Dromer F; Gueho E; Ronin O; Dupont B
J Clin Microbiol; 1993 Feb; 31(2):359-63. PubMed ID: 8432823
[TBL] [Abstract][Full Text] [Related]
10. Production of species-specific murine monoclonal antibodies against Cryptococcus neoformans which recognize a noncapsular exoantigen.
Hamilton AJ; Bartholomew MA; Figueroa J; Fenelon LE; Hay RJ
J Clin Microbiol; 1991 May; 29(5):980-4. PubMed ID: 2056065
[TBL] [Abstract][Full Text] [Related]
11. Protection against Experimental Cryptococcosis following Vaccination with Glucan Particles Containing Cryptococcus Alkaline Extracts.
Specht CA; Lee CK; Huang H; Tipper DJ; Shen ZT; Lodge JK; Leszyk J; Ostroff GR; Levitz SM
mBio; 2015 Dec; 6(6):e01905-15. PubMed ID: 26695631
[TBL] [Abstract][Full Text] [Related]
12. [Cryptococcosis caused by Cryptococcus neoformans var. Gattii. A case associated with acquired immunodeficiency syndrome (AIDS) in Kinshasa, Zaire].
Muyembe Tamfum JJ; Mupapa Kibadi D; Nganda L; Ngwala-Bikindu D; Kuezina T; Kela-We I; Vandepitte J
Med Trop (Mars); 1992; 52(4):435-8. PubMed ID: 1494313
[TBL] [Abstract][Full Text] [Related]
13. [Cryptococcus neoformans chemotyping. Review of the literature. New epidemiologic data on cryptococcosis. Our experience with the use of C.G.B. media in the study of this yeast].
de Melo NT; Lacaz Cda S; Charbel CE; Pereira AD; Heins-Vaccari EM; França-Netto AS; Machado Ldos R; Livramento JA
Rev Inst Med Trop Sao Paulo; 1993; 35(5):469-78. PubMed ID: 8115818
[TBL] [Abstract][Full Text] [Related]
14. Cryptococcus neoformans var. gattii in India.
Padhye AA; Chakrabarti A; Chander J; Kaufman L
J Med Vet Mycol; 1993; 31(2):165-8. PubMed ID: 8509953
[TBL] [Abstract][Full Text] [Related]
15. Infective capacity of Cryptococcus neoformans and Cryptococcus gattii in a human astrocytoma cell line.
Olave MC; Vargas-Zambrano JC; Celis AM; Castañeda E; González JM
Mycoses; 2017 Jul; 60(7):447-453. PubMed ID: 28338245
[TBL] [Abstract][Full Text] [Related]
16. Serum antibody response to active infection with Cryptococcus neoformans and its varieties in immunocompetent subjects.
Speed BR; Kaldor J; Cairns B; Pegorer M
J Med Vet Mycol; 1996; 34(3):187-93. PubMed ID: 8803799
[TBL] [Abstract][Full Text] [Related]
17. Urease inhibition by EDTA in the two varieties of Cryptococcus neoformans.
Kwon-Chung KJ; Wickes BL; Booth JL; Vishniac HS; Bennett JE
Infect Immun; 1987 Aug; 55(8):1751-4. PubMed ID: 3112009
[TBL] [Abstract][Full Text] [Related]
18. Cryptococcus neoformans- and Cryptococcus gattii-specific IgG, IgA and IgM differ among children and adults with and without cryptococcosis from Colombia.
Becerra-Álvarez P; Escandón P; Lizarazo J; Quirós-Gómez Ó; Firacative C
Med Mycol; 2022 Sep; 60(9):. PubMed ID: 36066645
[TBL] [Abstract][Full Text] [Related]
19. Galactoxylomannans from Cryptococcus neoformans varieties neoformans and grubii are structurally and antigenically variable.
De Jesus M; Chow SK; Cordero RJ; Frases S; Casadevall A
Eukaryot Cell; 2010 Jul; 9(7):1018-28. PubMed ID: 20061411
[TBL] [Abstract][Full Text] [Related]
20. Cryptococcus neoformans variety gattii.
Sorrell TC
Med Mycol; 2001 Apr; 39(2):155-68. PubMed ID: 11346263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
